Tin S. Kyaw
246 Clayton Road
Clayton, VIC 3168, Australia
Clayton, VIC 3168, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Beyond Reperfusion: Early Molecular Drivers and Therapeutic Opportunities in Acute Post-Infarction Cardiac Fibrosis.
Journal: International journal of molecular sciences
Published: March 30, 2026
Interferon regulatory factor 4 a master regulator of hypertensive kidney fibrosis and inflammation?
Journal: Journal of hypertension
Published: May 04, 2023
Myocarditis: causes, mechanisms, and evolving therapies.
Journal: Expert opinion on therapeutic targets
Published: March 22, 2023
Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts.
Journal: Frontiers in immunology
Published: September 09, 2022
Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?
Journal: Journal of hypertension
Published: April 07, 2021
Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas.
Journal: Circulation research
Published: July 17, 2020
Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.
Journal: European heart journal
Published: February 11, 2020
Evolving BAFF targeted therapies for preventing acute myocardial infarctions and ischemic strokes.
Journal: Expert opinion on therapeutic targets
Published: January 16, 2020
Early adaptive CD4+ T-cell immunity in atherosclerosis goes local.
Journal: Cardiovascular research
Published: October 12, 2019
B Cell and CD4 T Cell Interactions Promote Development of Atherosclerosis.
Journal: Frontiers in immunology
Published: October 11, 2019
Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgery.
Journal: Journal of leukocyte biology
Published: September 25, 2019
Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
Journal: Journal of the American Heart Association
Published: June 25, 2018
Last Updated: 09/26/2026